Enhanced anticancer activity of combined treatment of imatinib and dipyridamole in solid Ehrlich carcinoma-bearing mice.
Saved in:
| Title: | Enhanced anticancer activity of combined treatment of imatinib and dipyridamole in solid Ehrlich carcinoma-bearing mice. |
|---|---|
| Authors: | El-Sisi AE; Department of Pharmacology and Toxicology, college of pharmacy, University of Tanta, Tanta, Gharbia Governorate, Egypt., Sokar SS; Department of Pharmacology and Toxicology, college of pharmacy, University of Tanta, Tanta, Gharbia Governorate, Egypt., Ibrahim HA; Department of Pharmacology and Toxicology, college of pharmacy, University of Tanta, Tanta, Gharbia Governorate, Egypt. hanaa.abdelkareem@pharm.tanta.edu.eg., Abu-Risha SE; Department of Pharmacology and Toxicology, college of pharmacy, University of Tanta, Tanta, Gharbia Governorate, Egypt. |
| Source: | Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2020 Jun; Vol. 393 (6), pp. 1113-1129. Date of Electronic Publication: 2020 Jan 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
